Literature DB >> 15591214

Oxidized phospholipids trigger atherogenic inflammation in murine arteries.

Alexander Furnkranz1, Andreas Schober, Valery N Bochkov, Pavel Bashtrykov, Gerhard Kronke, Alexandra Kadl, Bernd R Binder, Christian Weber, Norbert Leitinger.   

Abstract

OBJECTIVE: Lipoprotein-derived phospholipid oxidation products have been implicated as candidate triggers of the inflammatory process in atherosclerosis. However, in vivo evidence regarding the impact of oxidized phospholipids on the artery wall thus far has been elusive. Therefore, the aim of this study was to investigate if structurally defined oxidized phospholipids induce expression of atherogenic chemokines and monocyte adhesion in intact murine arteries. METHODS AND
RESULTS: To model the accumulation of oxidized phospholipids in the arterial wall, oxidized 1-palmitoyl-2-arachidonoyl-sn-3-glycero-phosphorylcholine (OxPAPC) was topically applied to carotid arteries in mice using pluronic gel. Using quantitative reverse-transcriptase polymerase chain reaction (PCR) and immunohistochemistry, we show that OxPAPC induced a set of atherosclerosis-related genes, including monocyte chemotactic protein 1 (MCP-1) and keratinocyte-derived chemokine (KC), tissue factor (TF), interleukin 6 (IL-6), heme oxygenase 1 (HO-1), and early growth response 1 (EGR-1). OxPAPC-regulated chemokines were also expressed in atherosclerotic lesions of apolipoprotein E-deficient (ApoE-/-) mice. In isolated perfused carotid arteries, OxPAPC triggered rolling and firm adhesion of monocytes in a P-selectin and KC-dependent manner.
CONCLUSIONS: Oxidized phospholipids contribute to vascular inflammation in murine arteries in vivo, initiating atherogenic chemokine expression that leads to monocyte adhesion; therefore, they can be regarded as triggers of the inflammatory process in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15591214     DOI: 10.1161/01.ATV.0000153106.03644.a0

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  50 in total

1.  Reductive metabolism increases the proinflammatory activity of aldehyde phospholipids.

Authors:  Elena Vladykovskaya; Evgeny Ozhegov; J David Hoetker; Zhengzhi Xie; Yonis Ahmed; Jill Suttles; Sanjay Srivastava; Aruni Bhatnagar; Oleg A Barski
Journal:  J Lipid Res       Date:  2011-09-27       Impact factor: 5.922

2.  Cardioprotective effect of zingerone against oxidative stress, inflammation, and apoptosis induced by cisplatin or gamma radiation in rats.

Authors:  Ahmed F Soliman; Lobna M Anees; Doaa M Ibrahim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-07       Impact factor: 3.000

Review 3.  Connexin43 phosphorylation in brain, cardiac, endothelial and epithelial tissues.

Authors:  Lucrecia Márquez-Rosado; Joell L Solan; Clarence A Dunn; Rachael P Norris; Paul D Lampe
Journal:  Biochim Biophys Acta       Date:  2011-07-26

4.  High density lipoprotein level is negatively associated with the increase of oxidized low density lipoprotein lipids after a fatty meal.

Authors:  Sanna Tiainen; Markku Ahotupa; Petteri Ylinen; Tommi Vasankari
Journal:  Lipids       Date:  2014-10-31       Impact factor: 1.880

5.  Txnip ablation reduces vascular smooth muscle cell inflammation and ameliorates atherosclerosis in apolipoprotein E knockout mice.

Authors:  Chang Hyun Byon; Tieyan Han; Judy Wu; Simon T Hui
Journal:  Atherosclerosis       Date:  2015-06-03       Impact factor: 5.162

6.  Regulation of interleukin-6 expression in osteoblasts by oxidized phospholipids.

Authors:  Wendy Tseng; Jinxiu Lu; Gail A Bishop; Andrew D Watson; Andrew P Sage; Linda Demer; Yin Tintut
Journal:  J Lipid Res       Date:  2009-11-11       Impact factor: 5.922

7.  Oxidized phospholipid species promote in vivo differential cx43 phosphorylation and vascular smooth muscle cell proliferation.

Authors:  Scott R Johnstone; Jeremy Ross; Michael J Rizzo; Adam C Straub; Paul D Lampe; Norbert Leitinger; Brant E Isakson
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

8.  High density lipoproteins-based therapies for cardiovascular disease.

Authors:  Xuan Gao; Shujun Yuan
Journal:  J Cardiovasc Dis Res       Date:  2010-07

Review 9.  High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature.

Authors:  Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; Georgette M Buga; Greg Hough; Alan C Wagner; Alan M Fogelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11       Impact factor: 8.311

10.  Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside.

Authors:  Ana Villegas; Fernando A Gonzalez; Leopoldo Llorente; Santiago Redondo
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.